manjaro glp 1 agonist Mounjaro: What You Should Know About the New Type 2 Diabetes Medicine 9 Mounjaro Alternatives for Weight

doi: 10.1016/S0140-6736(21)00213-0 [DOI] [PubMed] [Google Scholar] 22.Nathan DM, Genuth S, Lachin J, et al

Use of ultrasound for gastric assessment Point-of-care ultrasound (PoCUS) helps determine gastric contents preoperatively

Viljoen, A

Medicine (Baltimore) 98(28):e15959 Verma S, McGuire DK, Bain SC, Bhatt DL, Leiter LA, Mazer CD, Monk Fries T, Pratley RE, Rasmussen S, Vrazic H et al (2020) Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials

One important context point the headline numbers miss: in STEP-1, while absolute lean mass dropped, lean body mass *as a proportion of total body mass* actually rose by roughly 3 percentage points